Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIG American International Group	$78.90 +0.7%	$79.98	$69.24 ▼ $88.07	$43.71B	0.68	4.55 million shs	5.14 million shs
CI Cigna Group	$308.30 +0.3%	$298.40	$256.89 ▼ $350.00	$82.29B	0.45	1.76 million shs	922,686 shs
JNJ Johnson & Johnson	$192.81 +0.5%	$181.27	$140.68 ▼ $194.48	$464.35B	0.4	8.90 million shs	6.24 million shs
NWSA News	$26.25 -0.5%	$28.98	$23.38 ▼ $31.61	$14.83B	1.17	3.48 million shs	2.36 million shs
PFE Pfizer	$24.72 -0.5%	$24.89	$20.92 ▼ $29.17	$140.52B	0.55	46.75 million shs	47.22 million shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIG American International Group	+0.87%	-5.47%	+1.84%	-1.34%	+1.08%
CI Cigna Group	+0.13%	+1.83%	+5.95%	+1.04%	-4.00%
JNJ Johnson & Johnson	-0.95%	+0.55%	+9.07%	+13.55%	+17.86%
NWSA News	-0.23%	-0.98%	-13.85%	-10.33%	+0.19%
PFE Pfizer	+0.65%	+1.29%	+3.37%	-1.91%	-14.13%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AIG American International Group	$78.90 +0.7%	$79.98	$69.24 ▼ $88.07	$43.71B	0.68	4.55 million shs	5.14 million shs
CI Cigna Group	$308.30 +0.3%	$298.40	$256.89 ▼ $350.00	$82.29B	0.45	1.76 million shs	922,686 shs
JNJ Johnson & Johnson	$192.81 +0.5%	$181.27	$140.68 ▼ $194.48	$464.35B	0.4	8.90 million shs	6.24 million shs
NWSA News	$26.25 -0.5%	$28.98	$23.38 ▼ $31.61	$14.83B	1.17	3.48 million shs	2.36 million shs
PFE Pfizer	$24.72 -0.5%	$24.89	$20.92 ▼ $29.17	$140.52B	0.55	46.75 million shs	47.22 million shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AIG American International Group	+0.87%	-5.47%	+1.84%	-1.34%	+1.08%
CI Cigna Group	+0.13%	+1.83%	+5.95%	+1.04%	-4.00%
JNJ Johnson & Johnson	-0.95%	+0.55%	+9.07%	+13.55%	+17.86%
NWSA News	-0.23%	-0.98%	-13.85%	-10.33%	+0.19%
PFE Pfizer	+0.65%	+1.29%	+3.37%	-1.91%	-14.13%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AIG American International Group	2.62	Moderate Buy	$89.81	13.83% Upside
CI Cigna Group	2.95	Moderate Buy	$369.89	19.98% Upside
JNJ Johnson & Johnson	2.77	Moderate Buy	$199.05	3.24% Upside
NWSA News	3.00	Buy	$38.62	47.11% Upside
PFE Pfizer	2.39	Hold	$28.13	13.80% Upside

Current Analyst Ratings Breakdown

Latest JNJ, PFE, NWSA, CI, and AIG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
10/22/2025	JNJ Johnson & Johnson	Johnson Rice Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Outperform ➝ Hold	$190.00
10/22/2025	JNJ Johnson & Johnson	Loop Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$190.00
10/20/2025	JNJ Johnson & Johnson	Daiwa America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
10/20/2025	JNJ Johnson & Johnson	Daiwa Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Neutral ➝ Outperform	$203.00
10/16/2025	JNJ Johnson & Johnson	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$210.00 ➝ $215.00
10/15/2025	JNJ Johnson & Johnson	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$210.00
10/15/2025	JNJ Johnson & Johnson	Raymond James Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$174.00 ➝ $209.00
10/15/2025	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$190.00
10/15/2025	JNJ Johnson & Johnson	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$165.00 ➝ $190.00
10/15/2025	CI Cigna Group	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$345.00 ➝ $325.00
10/15/2025	JNJ Johnson & Johnson	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$213.00 ➝ $215.00

(Data available from 10/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AIG American International Group	$27.74B	1.58	$11.52 per share	6.85	$70.20 per share	1.12
CI Cigna Group	$259.42B	0.32	$37.97 per share	8.12	$148.27 per share	2.08
JNJ Johnson & Johnson	$88.82B	5.23	$13.06 per share	14.76	$29.69 per share	6.49
NWSA News	$8.45B	1.75	$1.70 per share	15.43	$16.61 per share	1.58
PFE Pfizer	$63.63B	2.21	$4.37 per share	5.66	$15.62 per share	1.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AIG American International Group	-$1.40B	$5.28	14.94	10.34	0.77	11.51%	7.88%	2.04%	11/4/2025 (Confirmed)
CI Cigna Group	$3.43B	$18.32	16.83	9.33	0.90	1.92%	18.80%	5.02%	10/30/2025 (Estimated)
JNJ Johnson & Johnson	$14.07B	$10.36	18.61	17.42	2.28	27.26%	33.08%	13.30%	N/A
NWSA News	$1.18B	$2.08	12.62	23.44	N/A	13.21%	5.66%	3.19%	11/6/2025 (Estimated)
PFE Pfizer	$8.03B	$1.88	13.15	8.16	0.82	16.84%	21.42%	9.12%	11/4/2025 (Estimated)

Latest JNJ, PFE, NWSA, CI, and AIG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
11/6/2025	N/A	NWSA News	$0.18	N/A	N/A	N/A	$2.11 billion	N/A
11/4/2025	Q3 2025	AIG American International Group	$1.57	N/A	N/A	N/A	$6.82 billion	N/A
11/4/2025	Q3 2025	PFE Pfizer	$0.79	N/A	N/A	N/A	$16.94 billion	N/A
10/30/2025	Q3 2025	CI Cigna Group	$7.70	N/A	N/A	N/A	$66.40 billion	N/A
10/14/2025	Q3 2025	JNJ Johnson & Johnson	$2.76	$2.80	+$0.04	$2.12	$23.73 billion	$23.99 billion
8/6/2025	Q2 2025	AIG American International Group	$1.60	$1.81	+$0.21	$1.98	$6.81 billion	$6.77 billion
8/5/2025	Q4 2025	NWSA News	$0.19	$0.19	N/A	$1.31	$2.09 billion	$2.11 billion
8/5/2025	Q2 2025	PFE Pfizer	$0.58	$0.78	+$0.20	$0.51	$13.43 billion	$14.65 billion
7/31/2025	Q2 2025	CI Cigna Group	$7.15	$7.20	+$0.05	$5.71	$62.61 billion	$67.13 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AIG American International Group	$1.80	2.28%	N/A	34.09%	3 Years
CI Cigna Group	$6.04	1.96%	N/A	32.97%	5 Years
JNJ Johnson & Johnson	$5.20	2.70%	N/A	50.19%	64 Years
NWSA News	$0.20	0.76%	N/A	9.62%	N/A
PFE Pfizer	$1.72	6.96%	N/A	91.49%	16 Years

Latest JNJ, PFE, NWSA, CI, and AIG Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
10/14/2025	JNJ Johnson & Johnson	quarterly	$1.30	2.72%	11/25/2025	11/25/2025	12/9/2025
10/9/2025	PFE Pfizer	quarterly	$0.43	6.82%	11/7/2025	11/7/2025	12/1/2025
8/5/2025	NWSA News	half year 25	$0.10	0.7%	9/10/2025	9/10/2025	10/8/2025
8/6/2025	AIG American International Group	quarterly	$0.45	2.36%	9/16/2025	9/16/2025	9/30/2025
7/22/2025	CI Cigna Group	quarterly	$1.51	1.99%	9/4/2025	9/4/2025	9/18/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AIG American International Group	0.22	0.63	0.63
CI Cigna Group	0.65	0.71	0.71
JNJ Johnson & Johnson	0.50	1.01	0.76
NWSA News	0.21	1.84	1.72
PFE Pfizer	0.65	1.16	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AIG American International Group	90.60%
CI Cigna Group	86.99%
JNJ Johnson & Johnson	69.55%
NWSA News	66.97%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
AIG American International Group	0.50%
CI Cigna Group	0.70%
JNJ Johnson & Johnson	0.16%
NWSA News	13.60%
PFE Pfizer	0.06%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AIG American International Group	22,200	554.00 million	550.63 million	Optionable
CI Cigna Group	73,500	266.93 million	265.06 million	Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
NWSA News	22,300	564.97 million	488.14 million	Optionable
PFE Pfizer	81,000	5.69 billion	5.68 billion	Optionable

JNJ, PFE, NWSA, CI, and AIG Headlines

Recent News About These Companies

2 Safer High-Yield Stocks That Can Pay Boomers for Life

October 22 at 11:04 AM | 247wallst.com

Ethic Inc. Boosts Stock Holdings in Pfizer Inc. $PFE

October 22 at 9:38 AM | marketbeat.com

Family Capital Management Inc. Acquires Shares of 30,610 Pfizer Inc. $PFE

October 22 at 7:56 AM | marketbeat.com

Citizens & Northern Corp Purchases 12,934 Shares of Pfizer Inc. $PFE

October 22 at 7:16 AM | marketbeat.com

FNY Investment Advisers LLC Boosts Stock Holdings in Pfizer Inc. $PFE

October 22 at 7:15 AM | marketbeat.com

D.A. Davidson & CO. Buys 1,130,014 Shares of Pfizer Inc. $PFE

October 22 at 6:57 AM | marketbeat.com

Pfizer Inc. $PFE Stock Position Lifted by Phoenix Financial Ltd.

October 22 at 6:01 AM | marketbeat.com

Pfizer (PFE) Receives a Hold from Wells Fargo

October 21 at 11:17 PM | theglobeandmail.com

Pfizer Inc. (PFE) Announces Positive Results From its Phase 3 HER2CLIMB-05 Trial

October 21 at 1:14 PM | msn.com

Pfizer (PFE): Exploring Valuation as Shares Tick Higher Despite Sector Headwinds

October 21 at 1:14 PM | finance.yahoo.com

Jackson Thornton Wealth Management LLC Invests $272,000 in Pfizer Inc. $PFE

October 21 at 6:41 AM | marketbeat.com

Pfizer Inc. $PFE is Liberty One Investment Management LLC's 10th Largest Position

October 21 at 6:15 AM | marketbeat.com

DekaBank Deutsche Girozentrale Raises Stock Position in Pfizer Inc. $PFE

October 21 at 5:28 AM | marketbeat.com

VIRGINIA RETIREMENT SYSTEMS ET Al Buys New Holdings in Pfizer Inc. $PFE

October 21 at 4:41 AM | marketbeat.com

Pfizer's Q3 Non-Oncology Performance: Here's What to Expect

October 20 at 11:15 AM | zacks.com

Bogart Wealth LLC Increases Stake in Pfizer Inc. $PFE

October 20 at 7:13 AM | marketbeat.com

Schnieders Capital Management LLC Lowers Stake in Pfizer Inc. $PFE

October 20 at 6:59 AM | marketbeat.com

CORDA Investment Management LLC. Raises Stock Position in Pfizer Inc. $PFE

October 20 at 6:59 AM | marketbeat.com

Birmingham Capital Management Co. Inc. AL Sells 30,994 Shares of Pfizer Inc. $PFE

October 20 at 6:49 AM | marketbeat.com

Astellas, Pfizer announces results from Phase 3 EV-303 trial for PADCEV

October 19 at 9:20 PM | msn.com

Pfizer Inc. $PFE Shares Sold by Northeast Investment Management

October 19 at 6:58 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

JNJ, PFE, NWSA, CI, and AIG Company Descriptions

American International Group NYSE:AIG

$78.90 +0.52 (+0.67%)

Closing price 03:59 PM Eastern

Extended Trading

$77.67 -1.23 (-1.56%)

As of 04:32 PM Eastern

American International Group, Inc. offers insurance products for commercial, institutional, and individual customers in North America and internationally. It operates through three segments: General Insurance, Life and Retirement, and Other Operations. The General Insurance segment provides commercial and industrial property insurance, including business interruption and package insurance that cover exposure to made and natural disasters; general liability, environmental, commercial automobile liability, workers' compensation, excess casualty, and crisis management insurance products; and professional liability insurance. This segment offers marine, energy-related property insurance, aviation, political risk, trade credit, trade finance, and portfolio solutions, as well as operates reinsurance business; voluntary and sponsor-paid personal accident, and supplemental health products; and personal auto and personal property insurance. Its Life and Retirement segment offers individual retirement products, including variable, fixed index, and fixed annuities, as well as retail mutual funds; group retirement products comprising record-keeping, plan administrative and compliance services, financial planning, and advisory solutions; life insurance, including term and universal life insurance; and institutional markets products, which includes wrap products, structured settlement, pension risk transfer annuities, corporate and bank-owned life insurance, high net worth, and guaranteed investment contract products. It distributes its products through a network of brokers, agents, advisors, banks, and other distributors. The company was founded in 1919 and is headquartered in New York, New York.

Cigna Group NYSE:CI

$308.30 +0.80 (+0.26%)

Closing price 03:59 PM Eastern

Extended Trading

$306.17 -2.13 (-0.69%)

As of 04:32 PM Eastern

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Johnson & Johnson NYSE:JNJ

$192.81 +0.93 (+0.48%)

Closing price 03:59 PM Eastern

Extended Trading

$192.55 -0.26 (-0.13%)

As of 04:33 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

News NASDAQ:NWSA

$26.25 -0.13 (-0.49%)

Closing price 04:00 PM Eastern

Extended Trading

$26.25 0.00 (0.00%)

As of 04:13 PM Eastern

News Corporation, a media and information services company, creates and distributes authoritative and engaging content, and other products and services for consumers and businesses worldwide. It operates through six segments: Digital Real Estate Services, Subscription Video Services, Dow Jones, Book Publishing, News Media, and Other. The company distributes content and data products, including The Wall Street Journal, Barron's, MarketWatch, Investor's Business Daily, Factiva, Dow Jones Risk & Compliance, Dow Jones Newswires, and Dow Jones Energy through various media channels, such as newspapers, newswires, websites, mobile apps, newsletters, magazines, proprietary databases, live journalism, video, and podcasts. It also owns and operates Monday to Friday, Saturday and Sunday, weekly, and bi-weekly newspapers comprising The Australian, The Weekend Australian, The Daily Telegraph, The Sunday Telegraph, Herald Sun, Sunday Herald Sun, The Courier Mail, The Sunday Mail, The Advertiser, Sunday Mail, The Sun, The Sun on Sunday, The Times, The Sunday Times, and New York Post, as well as digital mastheads and other websites. In addition, the company publishes general fiction, nonfiction, children's, and religious books; provides sports, entertainment, and news services to pay-TV and streaming subscribers, and other commercial licensees through satellite and internet distribution; and broadcasts rights to live sporting events. Further, it offers property and property-related advertising and services on its websites and mobile applications; digital real estate services; and financial services. News Corporation was founded in 2012 and is headquartered in New York, New York.

Pfizer NYSE:PFE

$24.72 -0.14 (-0.54%)

Closing price 03:59 PM Eastern

Extended Trading

$24.73 +0.02 (+0.06%)

As of 04:33 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest JNJ, PFE, NWSA, CI, and AIG Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest JNJ, PFE, NWSA, CI, and AIG Earnings

Compare Dividends

Latest JNJ, PFE, NWSA, CI, and AIG Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

JNJ, PFE, NWSA, CI, and AIG Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

JNJ, PFE, NWSA, CI, and AIG Company Descriptions

American International Group NYSE:AIG

Cigna Group NYSE:CI

Johnson & Johnson NYSE:JNJ

News NASDAQ:NWSA

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools